EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

  

Myeloma Patients Europe (MPE) held the webinar “COVID-19 vaccines for myeloma patients: what you need to know” last Thursday, 29 April, to review the most recent updates on the approved COVID-19 vaccines in Europe and how they affect myeloma and AL amyloidosis patients.

The talk was given by Dr Anna Sureda, Head of the Hematology Department, Instituto Catalán de oncología (ICO), in Spain. Watch the recording below.

     

We received an important question regarding vaccines for family members and caregivers, but due to a lack of time it was unanswered during the webinar. As this is relevant for the patient community, a specific video responding to the question was filmed. Watch below for Dr Sureda’s response:

       






Recent news

» CAR-T cell therapy in myeloma

» Daratumumab subcutaneous, first approved treatment for newly diagnosed AL amyloidosis in Europe

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.